ARCHIVES

Cetuximab Plus Irinotecan Increases PFS In Metastatic Colorectal Cancer, EPIC Finds

This article is from The Cancer Letter archive.

Vol. 30 No. 4 | April 27, 2007

Download PDF Visit The Full Archive

Related Articles

“Realistic” Bypass Budget For 1983 asks $1.147Billion; Organ Site, Training, Control Would Get No Increases

September 18, 1981

In Brief: MSKCC Launches Molecular Oncology, Genomic Center

May 23, 2014

Long-term Follow-up Shows ADH and ALH Tissue Abnormalities Can Carry Similar Risk

January 31, 2014

Review Of NCI Intramural Program Offers Over 60 Recommendations For Change

July 7, 1995

Colon Cancer Screening Interval 5-10 Years Suggested

September 26, 2008

NCI Programs: BSA Approves concept For Grants Program In Statistical Modeling

July 16, 1999